$600,000 Funding Available for Immune Cell Engineering for Disease Monitoring in Type 1 Diabetes
Grants
Copyright © Targeted News Service, 2021
Copyright © Targeted News Service, 2021
2021-02-23
by MYRA TUGADE
WASHINGTON, Feb. 23 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a grant for immune cell engineering for targeted therapy and disease monitoring in type 1 diabetes.
The agency description of the grant states: "This initiative will support the engineering of immune cells to target the human pancreatic compartment to report on previously inaccessible information about diabetes initiation and progression, and to d . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Feb. 23 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a grant for immune cell engineering for targeted therapy and disease monitoring in type 1 diabetes.
The agency description of the grant states: "This initiative will support the engineering of immune cells to target the human pancreatic compartment to report on previously inaccessible information about diabetes initiation and progression, and to d . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com